
ICU Medical, Inc.
ICUI·NASDAQ
Last updated as of 2026-05-31 02:34 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
ICUI stock price change
On the last trading day, ICUI stock closed at 135.39 USD, with a price change of -2.51% for the day.
Trade stock perpsTrending stocks
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn moreICUI key data
Previous close135.39 USD
Market cap3.38B USD
Volume296.55K
P/E ratio73.11
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)1.85 USD
Net income (FY)732.00K USD
Revenue (FY)2.23B USD
Next report dateAug 10, 2026
EPS estimate1.930 USD
Revenue estimate532.45M USD USD
Shares float24.51M
Beta (1Y)1.00

ICU Medical, Inc. overview
Sector
Health technology
Industry
Medical Specialties
CEO
Vivek Jain
Headquarters
San Clemente
Website
icumed.com
Founded
1984
Employees (FY)
13K
Change (1Y)
−2K −13.33%
Revenue / Employee (1Y)
171.54K USD
Net income / Employee (1Y)
56.31 USD
ICUI stock price forecast
According to technical indicators for ICUI stock, the price is likely to fluctuate within the range of 126.70–152.41 USD over the next week. Market analysts predict that the price of ICUI stock will likely fluctuate within the range of 124.55–210.07 USD over the next months.
Based on 1-year price forecasts from 54 analysts, the highest estimate is 175.03 USD, while the lowest estimate is 84.46 USD.
For more information, please see the
ICUI stock price forecast
page.
Latest ICUI stock news
VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026
Finviz2026-03-10 14:00:12
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
Finviz2026-03-12 10:34:06
CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
Finviz2026-03-13 14:34:05
Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions
Finviz2026-03-17 12:03:51
SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026
Finviz2026-03-18 20:09:51
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
Finviz2026-03-19 13:49:12
ENvue Medical Expands Presence within a Major Michigan Health System and Grows U.S. Hospital Footprint to 39
Finviz2026-03-24 12:09:47
SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-25 20:09:40
Daxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026
Finviz2026-03-26 12:03:46
SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026
Finviz2026-03-30 12:24:09
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
Finviz2026-03-30 13:09:49
Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit
Finviz2026-03-31 20:24:09
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Finviz2026-04-06 13:00:53
Seres Therapeutics to Present at CARB-X Investor Day
Finviz2026-04-09 11:03:40
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
Finviz2026-04-14 12:06:46
VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026
Finviz2026-03-10 14:00:12
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
Finviz2026-03-12 10:34:06
CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
Finviz2026-03-13 14:34:05
Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions
Finviz2026-03-17 12:03:51
SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026
Finviz2026-03-18 20:09:51
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
Finviz2026-03-19 13:49:12

